100 results
Page 3 of 5
8-K
23ihbj4v7
11 Jan 22
Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones
9:00am
DEFA14A
8dl5uco
14 Apr 21
Additional proxy soliciting materials
4:10pm
D
ixmisy
30 Dec 20
$10M in equity, sold $10M, 3 investors
5:18pm
424B5
m2z 9y2etzh
15 Dec 20
Prospectus supplement for primary offering
4:57pm
424B5
y1m4 nkzsc
14 Dec 20
Prospectus supplement for primary offering
7:13am
8-K
EX-99.1
p3lj30i1
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
EX-99.2
vp3d6f6tkz3dkl8
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
S-3/A
n94mz9sw2
10 Aug 20
Shelf registration (amended)
4:11pm
S-3
EX-1.2
uemxl j0iq9
3 Aug 20
Shelf registration
9:00am
S-3
EX-4.3
ykfh8g42k57qugke667o
3 Aug 20
Shelf registration
9:00am
S-3
asx3ovj
3 Aug 20
Shelf registration
9:00am
8-K
EX-99.1
c8b5 t6am3
7 May 20
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
4:06pm